pentobarbital will reduce the level or outcome of bedaquiline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Stay clear of coadministration of bedaquiline with sturdy CYP3A4 inducers on account of opportunity for decreased therapeutic influencepentobarbital will lower the level or outcome of buprenorphine